Medical device manufacturers operate under quality mandates unlike any other industry. Patient safety is the governing constraint, regulatory requirements shape every design and process decision, and the consequences of a quality failure reaching a patient are uniquely serious. A Lumafield survey of 29 medical device quality leaders found that 38% consider regulatory and legal risk a top organizational priority, well above every other industry in the study.
Download this report and learn:
- How medical device quality programs are structured around patient safety first, and what that means for how organizations measure and prioritize quality costs
- Why scrap carries an outsized burden in medical devices, with 28% of respondents estimating 5-10% of total manufacturing cost lost to scrap, reflecting high material costs and precision requirements
- How new product introduction cycle times in medical devices are under more pressure than in any other industry surveyed, and what regulatory qualification of new suppliers is contributing to that
- Why AI adoption trails the study average across all major categories in medical devices, and how the validation burden of deploying new technology in a regulated environment is shaping that curve
- What the data reveals about where medical device quality organizations see the greatest opportunity to reduce cost without compromising the standards their products demand
Download the full report for medical device-specific findings on quality costs, regulatory pressure, and inspection practices across the industry.
